NASDAQ:CGEN
Compugen Ltd. Stock News
$2.16
+0.170 (+8.54%)
At Close: May 02, 2024
Bright Stock Buzz: Compugen Ltd. (NASDAQ:CGEN), Histogen Inc. (NASDAQ:HSTO)
04:08am, Monday, 22'nd Nov 2021 Stock Equity
Compugen Ltd. (CGEN) with the stream of -2.08% also noticed, India Histogen Inc. (HSTO) encountered a rapid change of -0.25% in the last hour of Fridays trading session. Compugen Ltd. The post Bright Stock Buzz: Compugen Ltd. (NASDAQ:CGEN), Histogen Inc. (NASDAQ:HSTO) appeared first on Stocks Equity .
FY2021 Earnings Forecast for Compugen Ltd. (NASDAQ:CGEN) Issued By Jefferies Financial Group
07:50am, Friday, 19'th Nov 2021 Transcript Daily
Compugen Ltd. (NASDAQ:CGEN) Stock analysts at Jefferies Financial Group raised their FY2021 earnings per share (EPS) estimates for Compugen in a research report issued to clients and investors on Monday, November 15th. Jefferies Financial Group analyst C. Howerton now expects that the biotechnology company will post earnings per share of ($0.39) for the year, []
After The Stock Fell -21.66% Over The Week, Is Compugen Ltd. (NASDAQ: CGEN) Still A Buy?
04:00pm, Thursday, 18'th Nov 2021 Marketing Sentinel
Compugen Ltd. (NASDAQ:CGEN)s traded shares stood at 1.81 million during the last session, with the companys beta value hitting 2.28. At the close of trading, the stocks price was $4.92, to imply a decrease of -4.65% or -$0.24 in intraday trading. The CGEN shares 52-week high remains $15.16, putting it -208.13% down since that peak After The Stock Fell -21.66% Over The Week, Is Compugen Ltd. (NASDAQ: CGEN) Still A Buy? Read More »
Walleye Capital LLC Sells 157,667 Shares of Compugen Ltd. (NASDAQ:CGEN)
01:24pm, Thursday, 18'th Nov 2021 Dakota Financial News
Walleye Capital LLC lessened its stake in shares of Compugen Ltd. (NASDAQ:CGEN) by 93.9% during the second quarter, Holdings Channel.com reports. The firm owned 10,173 shares of the biotechnology companys stock after selling 157,667 shares during the period. Walleye Capital LLCs holdings in Compugen were worth $84,000 as of its most recent SEC filing. Several []
Jefferies Financial Group Analysts Lift Earnings Estimates for Compugen Ltd. (NASDAQ:CGEN)
01:58pm, Wednesday, 17'th Nov 2021 Dakota Financial News
Compugen Ltd. (NASDAQ:CGEN) Jefferies Financial Group upped their FY2021 earnings per share (EPS) estimates for shares of Compugen in a research report issued to clients and investors on Monday, November 15th. Jefferies Financial Group analyst C. Howerton now anticipates that the biotechnology company will post earnings of ($0.39) per share for the year, up []
Flashy Stock: Compugen Ltd. (NASDAQ:CGEN), YPF Sociedad Anonima (NYSE:YPF)
11:58am, Wednesday, 17'th Nov 2021 Stock Equity
Compugen Ltd. (CGEN) with the stream of -3.67% also noticed, India YPF Sociedad Anonima (YPF) encountered a rapid change of -0.35% in the last hour of Tuesdays trading session. Compugen The post Flashy Stock: Compugen Ltd. (NASDAQ:CGEN), YPF Sociedad Anonima (NYSE:YPF) appeared first on Stocks Equity .
Why Compugen Stock Got Slammed Today
10:29pm, Monday, 15'th Nov 2021 The Motley Fool
A price cut from an analyst had some traders hitting the sell button.
Why Compugen Stock Got Slammed Today
05:29pm, Monday, 15'th Nov 2021
A price cut from an analyst had some traders hitting the sell button.
Compugen Posts Q3 Loss; Shares Drop 18%
05:04pm, Monday, 15'th Nov 2021 Smarter Analyst
Shares of Compugen (CGEN) plummeted 18% to close at $5.87 on November 12 after the Israel-based cancer immunotherapy company reported a loss for The post Compugen Posts Q3 Loss; Shares Drop 18% appeared first on Smarter Analyst .
Compugen Ltd. (NASDAQ: CGEN): Performance Report And Growth Forecast
01:30pm, Monday, 15'th Nov 2021 Marketing Sentinel
In the last trading session, 6.19 million Compugen Ltd. (NASDAQ:CGEN) shares changed hands as the companys beta touched 2.28. With the companys per share price at $5.87 changed hands at -$1.29 or -18.02% during last session, the market valuation stood at $600.91M. CGENs last price was a discount, traded about -158.26% off its 52-week high Compugen Ltd. (NASDAQ: CGEN): Performance Report And Growth Forecast Read More »
Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q3 2021 Results - Earnings Call Transcript
01:51pm, Friday, 12'th Nov 2021
Compugen Ltd. (CGEN) CEO Anat Cohen-Dayag on Q3 2021 Results - Earnings Call Transcript
Compugen (CGEN) Stock Up on Bristol Myers' $20M Investment
11:33am, Friday, 12'th Nov 2021
Compugen (CGEN) announces an expansion of its collaboration agreement with Bristol Myers Squibb and a $20 million equity investment by the latter.
Why Compugen Surged 14% Higher on Thursday
06:05pm, Thursday, 11'th Nov 2021
The company is deepening its partnership with Bristol Myers Squibb.
Compugen (CGEN) Stock: Why The Price Jumped
07:43am, Thursday, 11'th Nov 2021
The stock price of Compugen Ltd. (NASDAQ: CGEN) increased by over 15% pre-market today.
Compugen To Present Clinical Data from anti-TIGIT COM902 Monotherapy and Triple Combination Dose Escalation Studies at SITC 2021
08:05am, Friday, 01'st Oct 2021
HOLON, Israel, Oct. 1, 2021 /PRNewswire/ -- Compugen Ltd. (NASDAQ: CGEN), a clinical-stage cancer immunotherapy company and a leader in predictive target discovery, today announced that new clinica